Concepedia
2
Publications
21
Citations
H-Index
2024
Active since
Affiliations
Nanxi Mountain Hospital(Current)
Lian Deng is an author at Nanxi Mountain Hospital.
Publications per year
2024–2024
Cost-Effectiveness Analysis of Camrelizumab Plus Rivoceranib Versus Sorafenib as a First-Line Therapy for Unresectable Hepatocellular Carcinoma in the Chinese Health Care System
W.J. Lang, Lian Deng, Bei Huang et al. · Clinical Drug Investigation · 2024 · 11 citations
Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer in the Chinese healthcare system
W.J. Lang, Lian Deng, Meijun Lu et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2024 · 10 citations
Rows per page
1–2 of 2